Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistance

Objective To investigate the apoptosis and drug resistance mechanism of Src homolog and collagen homolog 3 (Shc3) in human hepatocellular carcinoma (HCC). Methods Human hepatocellular carcinoma cell lines HCCLM3 and HepG2 with stable Shc3 downregulation and their scramble cell control groups were se...

Full description

Bibliographic Details
Main Author: ZHANG Xin-ran, ZHANG Yi, GAO Hui-er, QIANG Zhao-yan, LI Yong-mei
Format: Article
Language:zho
Published: Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2020-04-01
Series:Jichu yixue yu linchuang
Subjects:
Online Access:http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a190667.pdf
_version_ 1797365721745850368
author ZHANG Xin-ran, ZHANG Yi, GAO Hui-er, QIANG Zhao-yan, LI Yong-mei
author_facet ZHANG Xin-ran, ZHANG Yi, GAO Hui-er, QIANG Zhao-yan, LI Yong-mei
author_sort ZHANG Xin-ran, ZHANG Yi, GAO Hui-er, QIANG Zhao-yan, LI Yong-mei
collection DOAJ
description Objective To investigate the apoptosis and drug resistance mechanism of Src homolog and collagen homolog 3 (Shc3) in human hepatocellular carcinoma (HCC). Methods Human hepatocellular carcinoma cell lines HCCLM3 and HepG2 with stable Shc3 downregulation and their scramble cell control groups were selected, Huh7 and HepG2 cells with stable Shc3 up-regulation and their pCDH control groups were selected. Protein expression levels of Shc3,MEK,p-MEK,ERK and p-ERK were determined by Western blot analysis. The mRNA level of Shc3 were determined by real-time PCR. Apoptotic experiment was used to observe cell apoptosis. CCK-8 assays were used to observe cell proliferation. Results Shc3 down-regulation and up-regulation cell lines were proved. Compared with scramble cells, Shc3 down-regulation significantly decreased activity of MEK/ERK pathway (P<0.05), promoted cell apoptosis significantly (P<0.05). Compared with pCDH cells, Shc3 up-regulation increased cell tolerance to sorafenib (P<0.05), Moreover, significantly enhanced activity of MEK/ERK pathway (P<0.05). Conclusions Shc3 may increase the resistance of HCC cells to sorafenib by interfering with apoptosis of HCC cells and activating MEK/ERK pathway. The results of this study provide theoretical basis and laboratory basis for targeting at Shc3 in the treatment of hepatocellular carcinoma.
first_indexed 2024-03-08T16:53:00Z
format Article
id doaj.art-6afa687a16a84fdf98b7b9b320fd02e3
institution Directory Open Access Journal
issn 1001-6325
language zho
last_indexed 2024-03-08T16:53:00Z
publishDate 2020-04-01
publisher Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
record_format Article
series Jichu yixue yu linchuang
spelling doaj.art-6afa687a16a84fdf98b7b9b320fd02e32024-01-05T03:14:34ZzhoInstitute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.Jichu yixue yu linchuang1001-63252020-04-01404473478Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistanceZHANG Xin-ran, ZHANG Yi, GAO Hui-er, QIANG Zhao-yan, LI Yong-mei01. Department of Pharmacy, Tianjin First Central Hospital, Tianjin 300192;;2. Department of Pharmacology, Basic Medicine College, Tianjin Medical University, Tianjin 300070;;3. Department of Pathogen Biology, Basic Medicine College, Tianjin Medical University, Tianjin 300070, ChinaObjective To investigate the apoptosis and drug resistance mechanism of Src homolog and collagen homolog 3 (Shc3) in human hepatocellular carcinoma (HCC). Methods Human hepatocellular carcinoma cell lines HCCLM3 and HepG2 with stable Shc3 downregulation and their scramble cell control groups were selected, Huh7 and HepG2 cells with stable Shc3 up-regulation and their pCDH control groups were selected. Protein expression levels of Shc3,MEK,p-MEK,ERK and p-ERK were determined by Western blot analysis. The mRNA level of Shc3 were determined by real-time PCR. Apoptotic experiment was used to observe cell apoptosis. CCK-8 assays were used to observe cell proliferation. Results Shc3 down-regulation and up-regulation cell lines were proved. Compared with scramble cells, Shc3 down-regulation significantly decreased activity of MEK/ERK pathway (P<0.05), promoted cell apoptosis significantly (P<0.05). Compared with pCDH cells, Shc3 up-regulation increased cell tolerance to sorafenib (P<0.05), Moreover, significantly enhanced activity of MEK/ERK pathway (P<0.05). Conclusions Shc3 may increase the resistance of HCC cells to sorafenib by interfering with apoptosis of HCC cells and activating MEK/ERK pathway. The results of this study provide theoretical basis and laboratory basis for targeting at Shc3 in the treatment of hepatocellular carcinoma.http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a190667.pdfhuman hepatocellular carcinoma|shc3|cell apoptosis|cell resistance
spellingShingle ZHANG Xin-ran, ZHANG Yi, GAO Hui-er, QIANG Zhao-yan, LI Yong-mei
Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistance
Jichu yixue yu linchuang
human hepatocellular carcinoma|shc3|cell apoptosis|cell resistance
title Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistance
title_full Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistance
title_fullStr Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistance
title_full_unstemmed Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistance
title_short Shc3 over-expression inhibits apoptosis of HCC cells and is involved in drug resistance
title_sort shc3 over expression inhibits apoptosis of hcc cells and is involved in drug resistance
topic human hepatocellular carcinoma|shc3|cell apoptosis|cell resistance
url http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a190667.pdf
work_keys_str_mv AT zhangxinranzhangyigaohuierqiangzhaoyanliyongmei shc3overexpressioninhibitsapoptosisofhcccellsandisinvolvedindrugresistance